Healthcare Services

Black lung disease market forecast through 2030 with growth insights

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Black Lung Disease Market Expected To Scale Between 2026 And 2030?

The black lung disease market size has experienced significant growth over recent years. It is projected to expand from $10.92 billion in 2025 to $12.51 billion in 2026, registering a compound annual growth rate (CAGR) of 14.6%. Historically, this expansion was largely due to increasing coal mining activities, prolonged exposure to coal dust among miners, limited early diagnostic access in mining regions, a rising incidence of respiratory occupational diseases, and a dependence on traditional diagnostic methods.

The black lung disease market is anticipated to experience swift expansion over the coming years. It is projected to reach $22.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.8%. This growth during the forecast period can be attributed to the greater uptake of sophisticated diagnostic technologies, increased funding for occupational health initiatives, expanding research into stem cell and regenerative treatments, improved availability of healthcare in mining areas, and stricter enforcement of worker health safety regulations. Key trends expected in the forecast period involve enhancements in diagnostic imaging for earlier detection, a heightened emphasis on preventative occupational health screening, increasing use of advanced pulmonary function tests, broader investigation into regenerative therapies, and more stringent monitoring of coal dust exposure.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

What Significant Factors Are Influencing The Black Lung Disease Market Expansion?

The rise in mining operations is projected to stimulate the expansion of the black lung disease market moving forward. These activities involve the extraction of valuable minerals, ores, and other geological resources from the Earth’s crust. Black lung disease, a condition affecting coal miners, results from these mining operations and the inhalation of coal mine dust, which contains hazardous carbon particles. For example, in July 2024, the International Energy Agency (IEA), a France-based intergovernmental organization, reported that global coal production in 2023 surged by 3.1% to 8,970 Mt, marking an all-time high, primarily influenced by major coal producers such as China, India, and Indonesia. Hence, the increase in mining activities is propelling the growth of the black lung disease market.

How Is The Black Lung Disease Market Segmented Across Different Segment Categories?

The black lung disease market covered in this report is segmented –

1) By Type: Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis

2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment

3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis

4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users

Subsegments:

1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis

2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms

Which Organizations Play A Role In The Black Lung Disease Market Landscape?

Major companies operating in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philips N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals plc, Lupin Limited

Get The Full Black Lung Disease Market Report:

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

Which Region Holds The Highest Market Share In The Black Lung Disease Market?

North America was the largest region in the black lung disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the black lung disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Black Lung Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

Browse Through More Reports Similar to the Global Black Lung Disease Market 2026, By The Business Research Company

Respiratory Disease Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report

Interstitial Lung Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Idiopathic Pulmonary Fibrosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/idiopathic-pulmonary-fibrosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795